Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

European Central Bank. https://www.ecb.europa.eu/stats/exchange/eurofxref/html/eurofxref-graph-usd.en.html (accessed Nov 2016). IMS Institute for Healthcare Informatics, 2016 IMS Institute for Healthcare Informatics, 2013 European Medicines Agency. European public assessment reports. http://www.ema.europa.eu/ema/index.jsp?mid=WC0b01ac058001d124&searchType=name&taxonomyPath=&genericsKeywordSearch=Submit&searchGenericType=biosimilars&keyword=Enter+keywords&alreadyLoaded=true&curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&treeNumber=&searchTab=searchByAuthType&pageNo=1 (accessed Nov 2016). European Medicines Agency.http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144941.pdf (accessed Dec 2016). Lee, 2012, Comparability and biosimilarity: considerations for the healthcare provider, Curr Med Res Opin, 28, 1053, 10.1185/03007995.2012.686902 Food and Drug Administration, 2015 European Medicines Agency, 2012 European Medicines Agency, 2014 World Health Organization, 2016 United States Food and Drug Administration, 2015 European Medicines Agency, 2013 European Medicines Agency, 2014 European Medicines Agency, 2005 European Medicines Agency.http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/q_and_a/q_and_a_detail_000129.jsp&mid=WC0b01ac0580533e0f (accessed Dec 2016). Niederwieser, 2011, Biosimilar agents in oncology/haematology: from approval to practice, Eur J Haematol, 86, 277, 10.1111/j.1600-0609.2010.01566.x Agency for Medicinal Products and Medical Devices of Croatia. http://www.halmed.hr/en/Lijekovi/Informacije-o-lijekovima/Bioloski-i-bioslicni-lijekovi/ (accessed Nov  2016). Kurki, 2015, Biosimilar regulation in the EU, Expert Rev Clin Pharmacol, 8, 649, 10.1586/17512433.2015.1071188 European Medicine Agency, 2012 European Commission, 2013 European Medicines Agency, 2014 European Medicines Agency, 2012 IMS Institute for Health Informatics, 2015 IMS Institute for Health Informatics, 2016 European Medicine Agency, 2014 European Medicines Agency, 2011 European Medicines Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000585/human_med_000643.jsp&mid=WC0b01ac058001d124 (accessed Nov 2016) Quintiles IMS. Biosimilars by region: Asia Pacific. http://www.quintiles.com/microsites/biosimilars-knowledge-connect/biosimilars-by-region/asia-pacific (accessed Nov 2016). Castañeda-Hernández, 2014, Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies, Joint Bone Spine, 81, 471, 10.1016/j.jbspin.2014.03.019